Relative Oral Bioavailability of BI 44847 as Suspension Compared to Tablet and the Influence of Food Anf of BI 44847 as Solution Compared to Tablet in Healthy Male Volunteers

NCT02211937 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

25

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 44847 solution, low dose
DRUG: BI 44847 suspension, high dose
DRUG: BI 44847 tablet, low dose
DRUG: BI 44847 tablet, high dose
OTHER: high fat breakfast

Sponsor

Boehringer Ingelheim